EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway

Wei Li, Qiwei Zhang, Ranli Gu, Lijun Zeng, Hao Liu iD

Animal Models and Experimental Medicine · 2023-12 · 6 (6) · 573-584

DOI: 10.1002/ame2.12342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 11.08.2023. Verfasst von Wei Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Cente…. Hauptthemen laut MEDLINE: Integrin alpha5, Osteogenesis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, CAMS Innovation Fund for Medical Sciences, Clinical Medicine Plus X - Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effect of platelet factor 4 (PF4) on bone marrow mesenchymal stem cells (BMMSCs) and osteoporosis is poorly understood. Therefore, this study aimed to evaluate the effects of PF4‐triggered bone destruction in mice and determine the underlying mechanism.

Methods

First, in vitro cell proliferation and cell cycle of BMMSCs were assessed using a CCK8 assay and flow cytometry, respectively. Osteogenic differentiation was confirmed using staining and quantification of alkaline phosphatase and Alizarin Red S. Next, an osteoporotic mouse model was established by performing bilateral ovariectomy (OVX). Furthermore, the PF4 concentrations were obtained using enzyme‐linked immunosorbent assay. The bone microarchitecture of the femur was evaluated using microCT and histological analyses. Finally, the key regulators of osteogenesis and pathways were investigated using quantitative real‐time polymerase chain reaction and Western blotting.

Results

Human PF4 widely and moderately decreased the cell proliferation and osteogenic differentiation ability of BMMSCs. Furthermore, the levels of PF4 in the serum and bone marrow were generally increased, whereas bone microarchitecture deteriorated due to OVX. Moreover, in vivo mouse PF4 supplementation triggered bone deterioration of the femur. In addition, several key regulators of osteogenesis were downregulated, and the integrin α5‐focal adhesion kinase‐extracellular signal‐regulated kinase (ITGA5‐FAK‐ERK) pathway was inhibited due to PF4 supplementation.

Conclusions

PF4 may be attributed to OVX‐induced bone loss triggered by the suppression of bone formation in vivo and alleviate BMMSC osteogenic differentiation by inhibiting the ITGA5‐FAK‐ERK pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Integrin alpha5OsteogenesisAnimalsFemaleHumansMiceCells, CulturedExtracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine KinasesMAP Kinase Signaling SystemPlatelet Factor 4Focal Adhesion Kinase 1Mitogen-Activated Protein Kinase Kinases

Stichwörter der Autor:innen

bone lossbone marrow mesenchymal stem cellsintegrin α5osteogenesisplatelet factor 4

Substanzen

Extracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine KinasesIntegrin alpha5Platelet Factor 4Focal Adhesion Kinase 1PTK2 protein, humanMitogen-Activated Protein Kinase Kinases

Autor:innen und Institutionen

  • Department of Oral Pathology, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biom…
  • Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Orthopedics, Beijing Hospital and National Center of Gerontology and Institute of Geriatrics Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Orthopedics, Beijing Eden Hospital, Beijing, China.
  • Department of Prosthodontics, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biom…
  • The Central Laboratory, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biomateria…

ORCID-Profile: Hao Liu

Förderung

  • Beijing Natural Science Foundation
  • CAMS Innovation Fund for Medical Sciences
  • Clinical Medicine Plus X - Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Li, W., Zhang, Q., Gu, R., Zeng, L., & Liu, H. (2023). Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway. Animal Models and Experimental Medicine, 6(6), 573-584. https://doi.org/10.1002/ame2.12342

Vancouver

Li W, Zhang Q, Gu R, Zeng L, Liu H. Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway. Animal Models and Experimental Medicine. 2023;6(6):573-584. doi:10.1002/ame2.12342

BibTeX
@article{Li2023,
  author = {Li, Wei and Zhang, Qiwei and Gu, Ranli and Zeng, Lijun and Liu, Hao},
  title = {Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway},
  journal = {Animal Models and Experimental Medicine},
  year = {2023},
  volume = {6},
  number = {6},
  pages = {573--584},
  doi = {10.1002/ame2.12342}
}
Kostenlos starten →